Featured Industry Insights
Uncovering Real-World Patient Insights With Social Media and NLP
Historically, drug researchers have relied on methods such as focus groups and questionnaires for first-person accounts of patient-reported outcomes. Social media has emerged as a lower cost alternative that is increasingly accepted as a reputable source of information by the research community.
Latest Industry Insights
How Do Spreadsheets Hold Back Pharma Innovation?
Technology Networks spoke to Jesse Harris to learn why spreadsheets can be a bottleneck for pharma research and explore how they compare to laboratory informatics tools.
Sustainability and Research: Finding a Balance
Laboratories often consume three to 10 times more energy than typical non-laboratory areas of universities. We spoke to Dr Susan Simon of the Medical Research Council to learn more about their commitment to sustainability and transformation to net zero by 2040.
Designing in Sustainability in Science
With a reliance on single-use plastics, significant waste and high energy usage, the carbon footprint of the biopharma industry is large. If we are to accelerate the path to net zero, it is therefore critical to ensure sustainability in science.
PFAS Strategic Roadmap: Highlights and Expected Impacts
In this interview, Dr. Craig Butt discusses some of the highlights from the Roadmap and its expected impacts.
Building Expertise in Ion Chromatography
In this interview, Gemma Ellison tells us more about the Ion Chromatography Education Hub, the range of content that it offers, and the benefits it provides IC users, whether they are new to the technique or have several years of experience.
2022: The Year We Implement COVID-19 Lessons Into Practice
As we seek a better tomorrow, here are three predictions from global life science and diagnostics company, PerkinElmer, that will lead to better health outcomes.
Transformative Models for Research and Drug Discovery
Technology Networks spoke to Dr. Mark Kotter, CEO and founder of bit.bio to learn about opti-ox™ and the development, benefits and applications of ioSkeletal Myocytes.
Addressing the Challenges of AAV Production
Technology Networks spoke to Emily Jackson-Holmes to learn more about the benefits of AAV vectors and reasons for the growing interest in their use.
Agilent Science Futures – An Interview With Joyce O’Grady
In this interview, Joyce explains the impact her work could have on society, tells us about the benefits that open-source technology has had on her research and highlights the importance of researcher support programs.
Reinventing Neuroscience Drug Discovery
Technology Networks had the pleasure of speaking with Saul Kato, the CEO of Herophilus, to learn more about how the company plans to reinvent neuro drug discovery, by combining human brain models, scaled biology and machine learning to decode brain disease.